We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Merck KGaA signs potential $1 billion deal with UK biotech, which further consolidating F-star’s growing reputation within the industry, only recently being named Life Science Innovation champion at Business Weekly Awards.
Merck KGaA, Darmstadt, Germany, a science and technology company, has announced a partnership with Palantir Technologies, developer of sophisticated data integration and analysis software, at Palantir's headquarters in Palo Alto, California.